http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0543593-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf5f014976f0572b47641dad01e6e189
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57581
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0806
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
filingDate 1992-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ab1b4dd8a0fe3311c10d9f7ff886ee0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43a0f3983c51fcbe560f1e7f5c59dd43
publicationDate 1993-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0543593-A
titleOfInvention Thymosin α1-fragment, and immunomodulator containing the compound
abstract (57) [Summary] (Modified) [Purpose] Immune deficiency, viral infection, rapid aging, There is provided a drug having an immunomodulatory action which can be used for the probability of tumor formation and especially for the treatment of cancer. A thymosin α 1 -fragment of Glu-Ala-Glu and a derivative of said compound having acetylserine, acetyldehydroalanine, acetyllysine or lysine if the N-terminal is not lysine as an amino acid additional to the N-terminal group, and A drug having an immunomodulatory effect, which comprises the compound.
priorityDate 1981-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7010502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7015704
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410862584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426792814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409995
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24847756
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62365
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601318
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5476
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID189
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID332962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415942433
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426285491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92907
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6992506
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516774
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420958359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415730448
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9543442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25201183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413351108
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411320080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18218200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7009623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226541663
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71464666
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16167214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9550
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413372769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79482
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426105809
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411319823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID192590

Total number of triples: 94.